CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 2 2025 10:15:22 提供 NetDania Notify

Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU

11 2 2025 06:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 2 2025 08:45:04 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

29 1 2025 13:22:37 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

28 1 2025 11:08:45 提供 NetDania Notify

Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference

28 1 2025 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

27 1 2025 10:55:04 提供 NetDania Notify

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025

08 1 2025 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 1 2025 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors

09 12 2024 06:00:00 提供 Nasdaq GlobeNewswire

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

03 12 2024 06:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

21 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

12 11 2024 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update

07 11 2024 06:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024

04 11 2024 06:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference

29 10 2024 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

16 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit

26 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference

05 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung

20 8 2024 07:00:00 提供 Nasdaq GlobeNewswire